arrhythmia & AF therapeutics

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/63

encourage image

There's no tags or description

Looks like no tags are added yet.

Last updated 12:43 AM on 9/29/26
Name
Mastery
Learn
Test
Matching
Spaced
Call with Kai
Chat

No analytics yet

Send a link to your students to track their progress

64 Terms

1
New cards

bradyarrhythmia

HR < 60 bpm

2
New cards

tachyarrhythmia

HR > 100 bpm

3
New cards

Wolff-Parkinson-White Syndrome

AV conduction goes through accessory pathway (Belt of Kent)

4
New cards

What meds to avoid in Wolff-Parkinson-White syndrome

BB

non-DHPs

digoxin

amiodarone

5
New cards

atrial fibrillation

uncoordinated atrial activation

irregularly, irregular pulse

6
New cards

atrial flutter

regular atrial activation

variable rapid pulse

7
New cards

paroxysmal AF

lasts ≤ 1 week

8
New cards

persistant AF

>1 week

9
New cards

long-standing persistent AF

>12 months

10
New cards

AF symptoms

often asymptomatic or vague/nonspecific (related to fatigue and negative sensations in chest)

11
New cards

Class 1A meds

moderate

Disopyramide

Quinidine

Procainamide

12
New cards

Class 1B meds

weak/fast

Lidocaine

Mexiletine

13
New cards

Class 1C meds

strong/slow

Flecainide

Propafenone

14
New cards

Class 2 drugs

beta blockers

15
New cards

Class 3 drugs (ADIDS)

K+ channel blockers

amiodarone

dronedarone

ibutilide

dofetilide

sotalol

16
New cards

Class 4 drugs

non-DHP CCBs

diltiazem, verapamil

17
New cards

ventricular rate control

slows HR to decrease symptoms

doesn’t actually get rid of AF

18
New cards

considerations of ventricular rate control (when shouldn’t it be used)

hemodynamically unstable

presence of HF

19
New cards

ventricular rate control resting HR goal

≤80 bpm (80-110 acceptable)

20
New cards

ventricular rate control moderate exercise HR goal

≤100 bpm

21
New cards

Bb contraindications

acute decompensated HF (lowers CO → lowers perfusion)

22
New cards

digoxin therapeutic drug monitoring goal for toxicity

0.8-2 ng/mL

23
New cards

can you use amiodarone as a rate control agent in HF and CV disease?

yes, but its not as effective as non-DHP CCBs

24
New cards

what does amiodarone require to work?

high dose load regimen to accelerate onset of action

25
New cards

why would someone need rhythm control over rate?

hemodynamically unstable

younger

shorter history of HF

more symptoms

high CV event risk

26
New cards

What drug classes are used for rhythm control?

Class 1A: disopyramide, quinidine, procainamide

Class 1C: flecainide, propafenone

Class III: amiodarone, dronedarone, ibutilide, dofetilide, sotalol

27
New cards

rhythm control

changing from AF to normal SR

28
New cards

what should class 1C drugs be avoided in?

patients with CV disease

29
New cards

when are class 1C drugs most effective

if AF ≤7 days

30
New cards

what class 3 drugs are class one recommendations for rhythm control?

dofetilide (PO)

ibutilide (IV)

31
New cards

sotalol efficiency?

low

32
New cards

CHA2DS2-VASc C

heart failure

1

33
New cards

CHA2DS2-VASc H

HTN (>140/>90)

1

34
New cards

CHA2DS2-VASc A2

≥75 y/o

2

35
New cards

CHA2DS2-VASc D

diabetes

1

36
New cards

CHA2DS2-VASc S2

prior stroke or TIA

or thromboembolism (DVT, VTE, etc)

2

37
New cards

CHA2DS2-VASc V

vascular disease

1

38
New cards

CHA2DS2-VASc A

age 65-74

1

39
New cards

CHA2DS2-VASc Sc

Sex category (female)

1

40
New cards

When to use oral anticoags to prevent stroke

CHA2DS2-VASc scores ≥2 (men) or ≥3 (women)

41
New cards

Should antiplatelets be used to prevent stroke?

Not by themselves or in combination therapy, they’re ineffective

42
New cards

In preventing a stroke, when should warfarin bridging be used?

high risk for thromboembolism, low risk for brain bleed (otherwise, don’t have to)

43
New cards

apixaban (eliquis) dose

5 mg PO BID

44
New cards

when to reduce eliquis dose

two of the following:

weight <60 kg

age >80 years

SCr > 1.5 mg/dL

45
New cards

What should eliquis dose be lowered to?

2.5 mg PO BID

46
New cards

older

rate control

47
New cards

younger (<65)

rhythm control

48
New cards

longer history of AF

rate control

49
New cards

shorter history of AF

rhythm control

50
New cards

fewer symptoms

rate control

51
New cards

more symptoms

rhythm control

52
New cards

Class II drugs for pt w/ HF

metoprolol, esmolol, propanolol

53
New cards

initial rhythm control for normal LV function in hospital

IV amiodarone

IV ibutilide

procainamide (only if can’t use above)

54
New cards

initial rhythm control for normal LV function outside of hospital

flecainide

propefanone

55
New cards

initial rhythm control for pt w/ HFrEF

(≤40% EF)

IV amiodarone

56
New cards

first-in-line rhythm control maintenance meds:

normal LV function (no MI or structural heart disease)

Dofetalide

Dronedarone

Flecainide

Propefanone

57
New cards

second-in-line rhythm control maintenance med:

normal LV function (no MI or structural heart disease)

amiodarone

58
New cards

3rd-in-line rhythm control maintenance med:

normal LV function (no MI or structural heart disease)

sotalol

59
New cards

1st-in-line rhythm control maintenance meds:

prior MI or structural heart disease

HFrEF (≤40%)

amiodarone

dofetilide

60
New cards

2nd-in-line rhythm control maintenance med:

prior MI or structural heart disease

HFrEF (≤40%)

sotalol

61
New cards

3rd-in-line rhythm control maintenance med:

prior MI or structural heart disease

HFrEF (≤40%)

flecainide

62
New cards

rate control med class options:

pt w/ LVEF > 40%

Bbs

non-DHP CCBs

(if still need rate control, can add other class option ± amiodarone)

63
New cards

rate control med class options:

pt w/ LVEF ≤ 40%, NOT decompensated HF

Bbs

digoxin

(if still need rate control, add other class option ± amiodarone)

64
New cards

rate control med class options:

pt w/ LVEF ≤ 40%, decompensated HF

digoxin

amiodarone